Ecuador will begin trials of three vaccines against COVID-19

Setback from US Justice for Donald Trump: TikTok ban suspended

A federal judge annulled the impossibility of downloads and updates, hours before the measure went into effect. The Chinese company argued that the...

Madura seeks economic recovery with new “anti-blockade law”

The Venezuelan President, Nicolas Maduro, announced that it will present to the National Constituent Assembly (ANC) an "anti-blockade law" that will help reverse...

Trump paid $ 750 in taxes in 2016 and 2017, according to ‘The New York Times’

The newspaper accesses 20 years of tax information that the president has tried to keep secret and that is under investigationDonald Trump has not...

They denounce that the Nicolás Maduro regime detained more than 30 people in four days of demonstrations in Venezuela

The protests were in seven municipalities. They complained for lack of water, electricity, gas and, also, fuel. Security agents tear-gassed demonstrations in western Venezuela,...

US mediates between Armenia and Azerbaijan to stop armed attacks

The United States Government urged the leaders of Armenia and Azerbaijan to "immediately cease" hostilities in Nagorno Karabakh, which are disputed by the...

At least 20,000 volunteers in Ecuador will participate in tests of three vaccines against COVID-19 starting in November, in a WHO project involving the Ministry of Health and the San Francisco de Quito University (USFQ).

The professor at that university, Enrique Terán, told Efe that the volunteers who are part of the WHO clinical study, called “Solidarity Vacunas”, must undergo a prior health evaluation to ensure that they are in the proper conditions for the application of the doses.

The investigator noted that, as this is an initial efficacy and safety study, The participation of people who have already been previously infected with the coronavirus is not recommended.

“This analysis tries to focus on the group most affected, that is, young adults between 20 and 50 years old,” he said.

The USFQ, together with the Public Health Portfolio, will begin the recruitment phase starting next October in Quito and Guayaquil, cities with the highest rate of infections nationwide, with more than 23,000 and 13,000 positives, respectively.

After the final presentation of the protocol with the study guidelines, its approval is in the hands of the National Agency for Regulation, Control and Sanitary Surveillance (ARCSA) and the ethics committees, before proceeding with their implementation.

Once the project begins, those who participate in the study on the experimental vaccines will be monitored by those in charge of the research.

At the express request of the WHO, it is not yet possible to know the three vaccines that will be tested in Ecuador, since the international Organization negotiates their supply with direct manufacturers.

However, Terán indicated that the doses to be tested in the country “are in their most developed state and are in phase three of execution in some countries.”

Last March, the WHO started this great clinical trial worldwide in order to find the most effective treatment for COVID-19.

Since last June, the USFQ and the Government have been in contact with representatives of the World Health Organization so that Ecuador can be part of the clinical trials that are currently being carried out worldwide.

Regarding the tests in the framework of the “Solidarity Vacuna” campaign, the director general of the WHO, Tedros Adhanom, indicated that the project “is designed to generate the solid data that we need, to show which treatments are the most effective.”

The Ecuadorian Ministry of Health is expected to rule on the matter in the coming days.



Related Articles